Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
Clinical trial NCT02928575 · UNKNOWN
Trial details
- NCT number
- NCT02928575
- Sponsor
- Bassam Abdulkarim
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2016-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.